Loading...

Cronos Group Inc.

CRON.TO•TSX
Healthcare
Drug Manufacturers - Specialty & Generic
CA$2.60
CA$-0.01(-0.38%)

Cronos Group Inc. (CRON.TO) AI-Powered Stock Analysis

See how Cronos Group Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.

Model Information

The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Cronos Group Inc. (CRON.TO) Stock Overall Grade

Cronos Group Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.

B+

Good

Grade Breakdown by Metric

See how each financial and market factor contributes to Cronos Group Inc.'s overall stock rating.

Forecast

C+

Score

55/100

Financial Growth

A

Score

80/100

Fundamental Growth

B

Score

68/100

Key Ratios

B+

Score

72/100

Sector Comparison

B+

Score

75/100

Industry Comparison

A

Score

80/100

S&P 500 Benchmark

A

Score

85/100

Analyst Consensus

C+

Score

50/100

Component Analysis Explained

Understand the key factors behind each Cronos Group Inc. stock grade, including financials, comparisons, and forecasts.

Frequently Asked Questions

;